Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Oct 24 2025
Jan 14 2026
Mar 24 2025
Sep 20 2025
May 13 2026